Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia

Young-Hoon Ko, Sung Won Jung, Sook Haeng Joe, Chang Hyun Lee, Hyun-Ghang Jeong, In Kwa Jung, Seung Hyun Kim, Moon-Soo Lee

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Objectives: Dysfunction of the hypothalamic-pituitary-gonadal axis may contribute to the pathophysiology of schizophrenia. Recent neuroendocrinological studies have suggested that gonadal sex hormones, including androgens and estrogen, play a significant role in the pathophysiology of schizophrenia. The purpose of this study was to determine any correlation between negative symptoms and the plasma levels of free testosterone, total testosterone, dehydroepiandrosterone sulfate, estradiol, and prolactin with consideration to depressive symptoms, extrapyramidal symptoms (EPS), and other factors including differences in age, diurnal variation of the serum hormone levels, and body fat composition. Methods: The subjects were 35 male inpatients with chronic schizophrenia aged 20-39 years. The patients' psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS). The Calgary Depression Scale for Schizophrenia (CDSS) and the Drug-induced EPS scale (DIEPSS) were also used to exclude the effects of depression or drug-induced movement disorders. Results: The PANSS negative scores had a significant inverse correlation with the serum total and free testosterone levels. The other hormone levels were not correlated with the PANSS negative scores. Moreover, a partial correlation analysis showed an inverse correlation between the PANSS negative subscores and the serum total and free testosterone levels after controlling for the DIEPSS and/or CDSS scores and age. Conclusions: This study indicates that total and free testosterone may play an important role in the severity of negative symptoms in male patients with schizophrenia.

Original languageEnglish
Pages (from-to)385-391
Number of pages7
JournalPsychoneuroendocrinology
Volume32
Issue number4
DOIs
Publication statusPublished - 2007 May 1

Fingerprint

Testosterone
Schizophrenia
Serum
Depression
Pharmaceutical Preparations
Hormones
Gonadal Hormones
Dehydroepiandrosterone Sulfate
Movement Disorders
Gonadal Steroid Hormones
Body Composition
Psychopathology
Prolactin
Androgens
Adipose Tissue
Inpatients
Estradiol
Estrogens

Keywords

  • Free testosterone
  • Negative symptoms
  • Schizophrenia
  • Testosterone

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. / Ko, Young-Hoon; Jung, Sung Won; Joe, Sook Haeng; Lee, Chang Hyun; Jeong, Hyun-Ghang; Jung, In Kwa; Kim, Seung Hyun; Lee, Moon-Soo.

In: Psychoneuroendocrinology, Vol. 32, No. 4, 01.05.2007, p. 385-391.

Research output: Contribution to journalArticle

@article{7b1307e8dd8947509da795ab3cf8594a,
title = "Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia",
abstract = "Objectives: Dysfunction of the hypothalamic-pituitary-gonadal axis may contribute to the pathophysiology of schizophrenia. Recent neuroendocrinological studies have suggested that gonadal sex hormones, including androgens and estrogen, play a significant role in the pathophysiology of schizophrenia. The purpose of this study was to determine any correlation between negative symptoms and the plasma levels of free testosterone, total testosterone, dehydroepiandrosterone sulfate, estradiol, and prolactin with consideration to depressive symptoms, extrapyramidal symptoms (EPS), and other factors including differences in age, diurnal variation of the serum hormone levels, and body fat composition. Methods: The subjects were 35 male inpatients with chronic schizophrenia aged 20-39 years. The patients' psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS). The Calgary Depression Scale for Schizophrenia (CDSS) and the Drug-induced EPS scale (DIEPSS) were also used to exclude the effects of depression or drug-induced movement disorders. Results: The PANSS negative scores had a significant inverse correlation with the serum total and free testosterone levels. The other hormone levels were not correlated with the PANSS negative scores. Moreover, a partial correlation analysis showed an inverse correlation between the PANSS negative subscores and the serum total and free testosterone levels after controlling for the DIEPSS and/or CDSS scores and age. Conclusions: This study indicates that total and free testosterone may play an important role in the severity of negative symptoms in male patients with schizophrenia.",
keywords = "Free testosterone, Negative symptoms, Schizophrenia, Testosterone",
author = "Young-Hoon Ko and Jung, {Sung Won} and Joe, {Sook Haeng} and Lee, {Chang Hyun} and Hyun-Ghang Jeong and Jung, {In Kwa} and Kim, {Seung Hyun} and Moon-Soo Lee",
year = "2007",
month = "5",
day = "1",
doi = "10.1016/j.psyneuen.2007.02.002",
language = "English",
volume = "32",
pages = "385--391",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia

AU - Ko, Young-Hoon

AU - Jung, Sung Won

AU - Joe, Sook Haeng

AU - Lee, Chang Hyun

AU - Jeong, Hyun-Ghang

AU - Jung, In Kwa

AU - Kim, Seung Hyun

AU - Lee, Moon-Soo

PY - 2007/5/1

Y1 - 2007/5/1

N2 - Objectives: Dysfunction of the hypothalamic-pituitary-gonadal axis may contribute to the pathophysiology of schizophrenia. Recent neuroendocrinological studies have suggested that gonadal sex hormones, including androgens and estrogen, play a significant role in the pathophysiology of schizophrenia. The purpose of this study was to determine any correlation between negative symptoms and the plasma levels of free testosterone, total testosterone, dehydroepiandrosterone sulfate, estradiol, and prolactin with consideration to depressive symptoms, extrapyramidal symptoms (EPS), and other factors including differences in age, diurnal variation of the serum hormone levels, and body fat composition. Methods: The subjects were 35 male inpatients with chronic schizophrenia aged 20-39 years. The patients' psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS). The Calgary Depression Scale for Schizophrenia (CDSS) and the Drug-induced EPS scale (DIEPSS) were also used to exclude the effects of depression or drug-induced movement disorders. Results: The PANSS negative scores had a significant inverse correlation with the serum total and free testosterone levels. The other hormone levels were not correlated with the PANSS negative scores. Moreover, a partial correlation analysis showed an inverse correlation between the PANSS negative subscores and the serum total and free testosterone levels after controlling for the DIEPSS and/or CDSS scores and age. Conclusions: This study indicates that total and free testosterone may play an important role in the severity of negative symptoms in male patients with schizophrenia.

AB - Objectives: Dysfunction of the hypothalamic-pituitary-gonadal axis may contribute to the pathophysiology of schizophrenia. Recent neuroendocrinological studies have suggested that gonadal sex hormones, including androgens and estrogen, play a significant role in the pathophysiology of schizophrenia. The purpose of this study was to determine any correlation between negative symptoms and the plasma levels of free testosterone, total testosterone, dehydroepiandrosterone sulfate, estradiol, and prolactin with consideration to depressive symptoms, extrapyramidal symptoms (EPS), and other factors including differences in age, diurnal variation of the serum hormone levels, and body fat composition. Methods: The subjects were 35 male inpatients with chronic schizophrenia aged 20-39 years. The patients' psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS). The Calgary Depression Scale for Schizophrenia (CDSS) and the Drug-induced EPS scale (DIEPSS) were also used to exclude the effects of depression or drug-induced movement disorders. Results: The PANSS negative scores had a significant inverse correlation with the serum total and free testosterone levels. The other hormone levels were not correlated with the PANSS negative scores. Moreover, a partial correlation analysis showed an inverse correlation between the PANSS negative subscores and the serum total and free testosterone levels after controlling for the DIEPSS and/or CDSS scores and age. Conclusions: This study indicates that total and free testosterone may play an important role in the severity of negative symptoms in male patients with schizophrenia.

KW - Free testosterone

KW - Negative symptoms

KW - Schizophrenia

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=34247281469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247281469&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2007.02.002

DO - 10.1016/j.psyneuen.2007.02.002

M3 - Article

C2 - 17395394

AN - SCOPUS:34247281469

VL - 32

SP - 385

EP - 391

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 4

ER -